Jason Dancy, MD
Physical Medicine & Rehabilitation · Brunswick, GANPI 1982643706
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,662 of the $5,834 with a category attached, or 62.8%. Boston Scientific accounts for 78.0% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2019 at $1,889 and has fallen 90.6% since, to $178 in 2025.
Across 85 payments — averaging $68.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$5K
- Stryker$876
- AbbVie$112
- Vericel Corporation$98
- Mimedx Group, Inc.$45
- Pacira Pharmaceuticals Incorporated$28
- plus $125 from 7 others
What the payments were for
- Travel & lodging$2,17237%
- Food & beverage$3,66263%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 61 | $4,551 |
| Stryker | 6 | $876 |
| AbbVie(2 entities) | 7 | $112 |
| Vericel Corporation | 2 | $98 |
| Mimedx Group, Inc. | 1 | $45 |
| Pacira Pharmaceuticals Incorporated | 1 | $28 |
| Averitas Pharma Inc. | 1 | $25 |
| Innovation Technologies Inc | 1 | $22 |
| Treace Medical Concepts, Inc. | 1 | $20 |
| Si-bone, Inc. | 1 | $16 |
| Molnlycke Health Care US, LLC | 1 | $15 |
| Bioventus LLC | 1 | $14 |
| Pfizer | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,834 in reported general payments places this provider in the 85th percentile of 214 physical medicine & rehabilitation providers in Georgia.
See all physical medicine & rehabilitation providers in Georgia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 422 | $4,095 |
| Celecoxib | 34 | $2,500 |
| Diclofenac Sodium | 184 | $2,455 |
| Tramadol Hcl | 411 | $2,447 |
| Lidocaine | 14 | $2,077 |
| Pregabalin | 58 | $658 |
| Methocarbamol | 80 | $543 |
| Chlorzoxazone | 12 | $454 |
| Duloxetine Hcl | 15 | $391 |
| Methylprednisolone | 58 | $363 |
| Tizanidine Hcl | 79 | $297 |
| Cyclobenzaprine Hcl | 44 | $270 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 30 | $230 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 15 | $172 |
| Meloxicam | 34 | $165 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Brunswick
- Erik ShawAtlanta$175K
- David TranAlpharetta$96K
- Payal FadiaDecatur$66K
- John MusserStockbridge$57K
- Abana AzariahAtlanta$22K
- Michael SchaufeleAtlanta$20K
- Gerald ChaiLawrenceville$16K
- Gerald BilskyAtlanta$16K
- Aiwane IboayaColumbus$16K
- Joseph HegartyBaxley$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.